Cash flow Danaher Corporation

Stocks

DHR

US2358511028

Advanced Medical Equipment & Technology

Real-time Estimate Cboe BZX Other stock markets 09:50:39 2026-07-20 am EDT			5-day change	1st Jan Change
203.52 ^USD	-0.15%		+1.34%	-11.39%

Jul. 15	Another Softer Inflation Surprise for Wall Street
Jul. 14	Danaher's Leica Biosystems to Acquire StatLab Medical Products	MT

a591c0d5a2ccf233bc1179d701a10590.f8zxKPujZwqRovzGELyu4JO68413wNnWOR2isWIMnKg.NabDSpz6JjPC6aWiJfiWucnVl_VOo63udEXMgjJt7sFOh8Z9ldIlUPb2vQ

Published financial data: DANAHER CORPORATION

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	29.45B	31.47B	23.89B	23.88B	24.57B
Total Revenues	29.45B	31.47B	23.89B	23.88B	24.57B
Cost of Goods Sold, Total	11.4B	12.52B	9.76B	9.64B	10.02B
Gross Profit	18.06B	18.95B	14.13B	14.23B	14.55B
Selling General & Admin Expenses, Total	8.15B	8.46B	7.24B	7.49B	7.58B
R&D Expenses	1.74B	1.74B	1.5B	1.58B	1.6B
Other Operating Expenses, Total	9.89B	10.21B	8.75B	9.08B	9.17B
Operating Income	8.17B	8.74B	5.38B	5.15B	5.38B
Interest Expense, Total	-238M	-211M	-286M	-278M	-265M
Interest And Investment Income	11M	41M	303M	117M	30M
Net Interest Expenses	-227M	-170M	17M	-161M	-235M
Other Non Operating Income (Expenses)	-	-	-	-	-
EBT, Excl. Unusual Items	7.94B	8.57B	5.4B	4.99B	5.14B
Restructuring Charges	-	-	-	-	-
Merger & Related Restructuring Charges	-104M	-	-95M	-25M	-
Gain (Loss) On Sale Of Investments	401M	-271M	-182M	-57M	-248M
Gain (Loss) On Sale Of Assets	13M	-	-	-	20M
Asset Writedown	-10M	-9M	-77M	-265M	-692M
Legal Settlements	-547M	-	-	-	-
Other Unusual Items	-96M	-	-	-	10M
EBT, Incl. Unusual Items	7.6B	8.29B	5.04B	4.65B	4.23B
Income Tax Expense	1.25B	1.08B	823M	747M	633M
Earnings From Continuing Operations	6.35B	7.21B	4.22B	3.9B	3.6B
Earnings Of Discontinued Operations	86M	-	543M	-	14M
Net Income to Company	6.43B	7.21B	4.76B	3.9B	3.61B
Net Income - (IS)	6.43B	7.21B	4.76B	3.9B	3.61B
Preferred Dividend and Other Adjustments	164M	106M	21M	-	-
Net Income to Common Incl Extra Items	6.27B	7.1B	4.74B	3.9B	3.61B
Net Income to Common Excl. Extra Items	6.18B	7.1B	4.2B	3.9B	3.6B
Per Share Items
Net EPS - Basic	8.77	9.8	6.44	5.33	5.07
Basic EPS - Continuing Operations	8.65	9.8	5.7	5.33	5.05
Basic Weighted Average Shares Outstanding	715M	725M	736M	731M	713M
Net EPS - Diluted	8.61	9.66	6.38	5.29	5.05
Diluted EPS - Continuing Operations	8.5	9.66	5.65	5.29	5.03
Diluted Weighted Average Shares Outstanding	737M	737M	743M	737M	716M
Normalized Basic EPS	6.95	7.39	4.58	4.27	4.51
Normalized Diluted EPS	6.74	7.27	4.54	4.23	4.49
Dividend Per Share	0.84	1	1.05	1.08	1.28
Payout Ratio	11.53	11.35	17.23	19.7	24.29
American Depositary Receipts Ratio (ADR)	0.04	0.04	0.04	0.04	0.04
Supplemental Items
EBITDA	10.34B	10.96B	7.55B	7.51B	7.82B
EBITA	9.62B	10.23B	6.87B	6.78B	7.08B
EBIT	8.17B	8.74B	5.38B	5.15B	5.38B
EBITDAR	10.64B	11.28B	7.82B	7.8B	8.14B
Effective Tax Rate - (Ratio)	16.46	13.06	16.32	16.08	14.95
Current Domestic Taxes	346M	413M	756M	301M	298M
Current Foreign Taxes	1.13B	1.23B	1.27B	929M	775M
Total Current Taxes	1.48B	1.64B	2.03B	1.23B	1.07B
Deferred Domestic Taxes	-206M	-400M	-866M	-342M	-307M
Deferred Foreign Taxes	-23M	-159M	-338M	-141M	-133M
Total Deferred Taxes	-229M	-559M	-1.2B	-483M	-440M
Normalized Net Income	4.96B	5.36B	3.37B	3.12B	3.21B
Non-Cash Pension Expense	-44M	-47M	-10M	-3M	-8M
Supplemental Operating Expense Items
Research And Development Expense From Footnotes	1.74B	1.74B	1.5B	1.58B	1.6B
Net Rental Expense, Total	305M	312M	274M	299M	316M
Imputed Operating Lease Interest Expense	25.55M	23.93M	31.23M	36.26M	36.37M
Imputed Operating Lease Depreciation	279M	288M	243M	263M	280M
Stock-Based Comp., SG&A Exp. (Total)	218M	336M	306M	288M	298M
Total Stock-Based Compensation	218M	336M	306M	288M	298M

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	2.59B	6B	5.86B	2.08B	4.62B
Total Cash And Short Term Investments	2.59B	6B	5.86B	2.08B	4.62B
Accounts Receivable, Total	4.63B	5.01B	3.98B	3.54B	3.91B
Other Receivables	-	962M	715M	853M	989M
Total Receivables	4.63B	5.97B	4.69B	4.39B	4.9B
Inventory	2.77B	3.11B	2.59B	2.33B	2.49B
Prepaid Expenses	1.66B	802M	771M	699M	750M
Other Current Assets, Total	-	6M	17M	-	-
Total Current Assets	11.65B	15.88B	13.94B	9.5B	12.76B
Gross Property Plant And Equipment	8.3B	8.85B	9.43B	10.18B	11.51B
Accumulated Depreciation	-3.46B	-3.89B	-3.83B	-4.1B	-4.77B
Net Property Plant And Equipment	4.83B	4.96B	5.6B	6.07B	6.74B
Long-term Investments	20M	11M	5M	-	-
Goodwill	41.18B	39.75B	41.61B	40.5B	43.15B
Other Intangibles, Total	22.84B	20.3B	20.75B	18.57B	17.82B
Deferred Tax Assets Long-Term	1.23B	1.43B	1.9B	2.29B	2.53B
Other Long-Term Assets, Total	1.42B	2.02B	682M	614M	465M
Total Assets	83.18B	84.35B	84.49B	77.54B	83.46B
Liabilities
Accounts Payable, Total	2.57B	2.3B	1.77B	1.75B	1.84B
Accrued Expenses, Total	1.66B	1.63B	1.34B	1.34B	1.43B
Current Portion of Long-Term Debt	8M	591M	1.7B	505M	2M
Current Portion of Leases	207M	199M	180M	173M	199M
Current Income Taxes Payable	707M	691M	582M	568M	532M
Unearned Revenue Current, Total	1.61B	1.65B	1.46B	1.3B	1.35B
Other Current Liabilities	1.37B	1.33B	1.25B	1.16B	1.44B
Total Current Liabilities	8.14B	8.39B	8.27B	6.8B	6.81B
Long-Term Debt	22.17B	19.09B	16.71B	15.5B	18.42B
Long-Term Leases	889M	863M	954M	968M	1.08B
Unearned Revenue Non Current	213M	235M	249M	232M	231M
Pension & Other Post Retirement Benefits	876M	506M	544M	560M	608M
Other Non Current Liabilities	5.72B	5.18B	4.27B	3.93B	3.78B
Total Liabilities	38.01B	34.26B	31B	27.99B	30.92B
Preferred Stock Convertible	3.27B	1.67B	-	-	-
Total Preferred Equity	3.27B	1.67B	-	-	-
Common Stock, Total	9M	9M	9M	9M	9M
Additional Paid In Capital	10.09B	12.07B	14.15B	16.73B	17.19B
Retained Earnings	32.83B	39.2B	41.07B	44.19B	46.89B
Treasury Stock	-	-	-	-8.16B	-11.35B
Comprehensive Income and Other	-1.03B	-2.87B	-1.75B	-3.22B	-207M
Total Common Equity	41.9B	48.41B	53.49B	49.54B	52.53B
Minority Interest	10M	8M	4M	7M	7M
Total Equity	45.18B	50.09B	53.49B	49.55B	52.54B
Total Liabilities And Equity	83.18B	84.35B	84.49B	77.54B	83.46B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	715M	729M	740M	715M	707M
ECS Total Common Shares Outstanding	715M	728M	739M	719M	707M
Book Value / Share	58.6	66.48	72.36	68.9	74.32
Tangible Book Value	-22.13B	-11.64B	-8.87B	-9.52B	-8.43B
Tangible Book Value Per Share	-30.95	-15.98	-12	-13.24	-11.93
Total Debt	23.27B	20.74B	19.54B	17.15B	19.7B
Net Debt	20.69B	14.74B	13.67B	15.07B	15.08B
Debt Equivalent of Unfunded Proj. Benefit Obligation	813M	459M	503M	313M	227M
Debt Equivalent Oper. Leases	2.44B	2.5B	2.19B	2.39B	2.53B
Minority Interest, Total (Incl. Fin. Div)	10M	8M	4M	7M	7M
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Raw Materials, Total	951M	1.13B	853M	720M	733M
Inventories - Work In Process, Total	473M	473M	459M	465M	469M
Inventories - Finished Goods, Total	1.34B	1.5B	1.28B	1.14B	1.29B
Land - (BS)	203M	216M	210M	230M	233M
Buildings, Total	1.68B	1.99B	2.27B	2.55B	3.05B
Machinery, Total	3.61B	3.94B	4.11B	4.43B	4.87B
Full Time Employees	78K	79K	61K	61K	58K
Part Time Employees	2K	2K	2K	2K	2K
Assets on Operating Lease - Gross	1.77B	1.7B	1.79B	1.88B	2.14B
Accumulated Allowance for Doubtful Accounts (Supple)	124M	126M	120M	113M	114M
Order Backlog	-	-	-	-	-

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	6.43B	7.21B	4.76B	3.9B	3.61B
Depreciation & Amortization - CF	718M	738M	675M	721M	750M
Amortization of Goodwill and Intangible Assets - (CF)	1.45B	1.48B	1.49B	1.63B	1.7B
Depreciation & Amortization, Total	2.17B	2.22B	2.17B	2.35B	2.45B
(Gain) Loss From Sale Of Asset	-13M	-	-	-	-9M
(Gain) Loss on Sale of Investments - (CF)	-401M	271M	182M	57M	237M
Asset Writedown & Restructuring Costs	-	-	-	265M	562M
Stock-Based Compensation (CF)	218M	336M	306M	288M	298M
Net Cash From Discontinued Operations	-	-	674M	-	-
Other Operating Activities, Total	611M	-	-535M	25M	-14M
Change In Accounts Receivable	-611M	-477M	322M	331M	-216M
Change In Inventories	-502M	-486M	185M	147M	-58M
Change In Accounts Payable	549M	5M	-149M	19M	9M
Change In Deferred Taxes	-229M	-559M	-1.2B	-483M	-440M
Change in Other Net Operating Assets	135M	-2M	453M	-212M	-14M
Cash from Operations	8.36B	8.52B	7.16B	6.69B	6.42B
Capital Expenditure	-1.29B	-1.15B	-1.38B	-1.39B	-1.16B
Sale of Property, Plant, and Equipment	13M	9M	12M	13M	33M
Cash Acquisitions	-10.96B	-637M	-5.61B	-558M	-
Divestitures	26M	-	-	-	9M
Investment in Marketable and Equity Securities, Total	-808M	-505M	-111M	-78M	-115M
Other Investing Activities, Total	37M	51M	11M	34M	33M
Cash from Investing	-12.99B	-2.23B	-7.08B	-1.98B	-1.2B
Short Term Debt Issued, Total	2.26B	-	-	5M	-
Long-Term Debt Issued, Total	984M	-	-	-	1.56B
Total Debt Issued	3.25B	-	-	5M	1.56B
Short Term Debt Repaid, Total	-	-723M	-1.01B	-	-11M
Long-Term Debt Repaid, Total	-1.19B	-965M	-620M	-1.67B	-500M
Total Debt Repaid	-1.19B	-1.69B	-1.63B	-1.67B	-511M
Issuance of Common Stock	86M	31M	68M	162M	85M
Repurchase of Common Stock	-	-	-	-5.98B	-3.09B
Issuance of Preferred Stock	-	-	-	-	-
Common Dividends Paid	-578M	-693M	-778M	-768M	-878M
Preferred Dividends Paid	-164M	-125M	-43M	-	-
Common & Preferred Stock Dividends Paid	-742M	-818M	-821M	-768M	-878M
Other Financing Activities, Total	-112M	-95M	2.11B	-131M	-125M
Cash from Financing	1.3B	-2.57B	-273M	-8.38B	-2.96B
Foreign Exchange Rate Adjustments	-115M	-306M	59M	-108M	278M
Net Change in Cash	-3.45B	3.41B	-131M	-3.79B	2.54B
Supplemental Items
Cash Interest Paid	452M	347M	392M	370M	331M
Cash Income Tax Paid (Refund)	1.7B	1.8B	1.8B	1.3B	1.2B
Levered Free Cash Flow	5.48B	5.59B	4.86B	4.67B	4.55B
Unlevered Free Cash Flow	5.62B	5.72B	5.04B	4.84B	4.71B
Change In Net Working Capital	572M	1.15B	-583M	-375M	236M
Net Debt Issued / Repaid	2.06B	-1.69B	-1.63B	-1.67B	1.04B

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	6.41	6.52	3.98	3.98	4.18
Return on Total Capital	7.83	7.85	4.68	4.61	4.84
Return On Equity %	14.94	15.13	8.15	7.57	7.05
Return on Common Equity	15.77	15.73	8.24	7.57	7.05
Margin Analysis
Gross Profit Margin %	61.3	60.21	59.14	59.61	59.23
SG&A Margin	27.66	26.89	30.33	31.38	30.84
EBITDA Margin %	35.09	34.84	31.59	31.44	31.85
EBITA Margin %	32.66	32.49	28.77	28.42	28.8
EBIT Margin %	27.73	27.78	22.52	21.59	21.89
Income From Continuing Operations Margin %	21.55	22.91	17.67	16.33	14.65
Net Income Margin %	21.84	22.91	19.94	16.33	14.71
Net Avail. For Common Margin %	20.99	22.57	17.58	16.33	14.65
Normalized Net Income Margin	16.85	17.02	14.12	13.07	13.08
Levered Free Cash Flow Margin	18.59	17.75	20.33	19.56	18.51
Unlevered Free Cash Flow Margin	19.1	18.17	21.08	20.29	19.19
Asset Turnover
Asset Turnover	0.37	0.38	0.28	0.29	0.31
Fixed Assets Turnover	6.52	6.43	4.69	4.09	3.83
Receivables Turnover (Average Receivables)	6.74	6.48	5.86	6.4	6.6
Inventory Turnover (Average Inventory)	4.51	4.26	3.64	3.92	4.16
Short Term Liquidity
Current Ratio	1.43	1.89	1.68	1.4	1.87
Quick Ratio	0.89	1.43	1.28	0.95	1.4
Operating Cash Flow to Current Liabilities	1.03	1.02	0.87	0.98	0.94
Days Sales Outstanding (Average Receivables)	54.16	56.33	62.3	57.17	55.34
Days Outstanding Inventory (Average Inventory)	81.01	85.65	100.2	93.44	87.81
Average Days Payable Outstanding	70.99	69.01	68.93	68.65	64.52
Cash Conversion Cycle (Average Days)	64.18	72.97	93.57	81.95	78.63
Long Term Solvency
Total Debt/Equity	51.51	41.4	36.52	34.6	37.49
Total Debt / Total Capital	34	29.28	26.75	25.71	27.27
LT Debt/Equity	51.04	39.83	33.02	33.24	37.1
Long-Term Debt / Total Capital	33.68	28.16	24.18	24.69	26.99
Total Liabilities / Total Assets	45.69	40.62	36.69	36.1	37.05
EBIT / Interest Expense	34.32	41.43	18.81	18.54	20.29
EBITDA / Interest Expense	44.71	53.44	27.35	28.08	30.72
(EBITDA - Capex) / Interest Expense	39.27	47.98	22.51	23.07	26.36
Total Debt / EBITDA	2.19	1.84	2.5	2.2	2.42
Net Debt / EBITDA	1.94	1.31	1.75	1.93	1.85
Total Debt / (EBITDA - Capex)	2.49	2.05	3.03	2.67	2.82
Net Debt / (EBITDA - Capex)	2.21	1.46	2.12	2.35	2.16
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	32.17	6.85	-10.33	-0.06	2.9
Gross Profit, 1 Yr. Growth %	38.43	4.95	-12.72	0.72	2.26
EBITDA, 1 Yr. Growth %	56.32	6.08	-22.29	-0.54	3.66
EBITA, 1 Yr. Growth %	60.97	6.32	-23.76	-1.27	3.62
EBIT, 1 Yr. Growth %	68.86	7.03	-29.01	-4.22	3.48
Earnings From Cont. Operations, 1 Yr. Growth %	74.08	13.58	-33.3	-7.63	-7.67
Net Income, 1 Yr. Growth %	76.44	12.06	-33.92	-18.16	-7.31
Normalized Net Income, 1 Yr. Growth %	71.22	7.95	-27.22	-7.5	2.12
Diluted EPS Before Extra, 1 Yr. Growth %	73.94	13.72	-33.28	-6.37	-4.92
Accounts Receivable, 1 Yr. Growth %	12.68	6.42	-4.86	-9.82	10.63
Inventory, 1 Yr. Growth %	20.72	12.4	-6.18	-10.18	6.82
Net Property, Plant and Equip., 1 Yr. Growth %	14.91	2.61	22.03	8.37	11.05
Total Assets, 1 Yr. Growth %	9.22	1.4	0.16	-8.22	7.64
Tangible Book Value, 1 Yr. Growth %	9.52	-47.41	2.13	7.37	-11.43
Common Equity, 1 Yr. Growth %	14.8	15.55	10.48	-7.37	6.04
Cash From Operations, 1 Yr. Growth %	34.63	1.93	-15.91	-6.64	-4.07
Capital Expenditures, 1 Yr. Growth %	63.59	-10.97	23.7	0.65	-16.95
Levered Free Cash Flow, 1 Yr. Growth %	19.59	2	1.2	-3.83	-3.17
Unlevered Free Cash Flow, 1 Yr. Growth %	18.39	1.65	2.2	-3.79	-3.22
Dividend Per Share, 1 Yr. Growth %	16.67	19.05	5	2.86	18.52
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	28.23	18.84	-1.86	-5.34	1.41
Gross Profit, 2 Yr. CAGR %	34.48	20.53	-4.04	-6.24	1.78
EBITDA, 2 Yr. CAGR %	52.06	28.99	-9.15	-12.09	2.38
EBITA, 2 Yr. CAGR %	56.92	31.06	-9.93	-13.24	2.07
EBIT, 2 Yr. CAGR %	57.78	34.74	-12.83	-17.54	0.73
Earnings From Cont. Operations, 2 Yr. CAGR %	61.55	40.61	-11.97	-21.5	-7.65
Net Income, 2 Yr. CAGR %	46.24	40.61	-13.94	-26.46	-12.9
Normalized Net Income, 2 Yr. CAGR %	54.84	36.27	-11.31	-17.95	-1.65
Diluted EPS Before Extra, 2 Yr. CAGR %	61.42	40.65	-11.88	-20.96	-5.65
Accounts Receivable, 2 Yr. CAGR %	19.04	10.39	-8.08	-8	-0.11
Inventory, 2 Yr. CAGR %	30.37	16.49	-3.18	-8.2	-2.04
Net Property, Plant and Equip., 2 Yr. CAGR %	25.53	8.59	7.71	15	9.7
Total Assets, 2 Yr. CAGR %	15.75	5.24	0.78	-4.12	-0.61
Tangible Book Value, 2 Yr. CAGR %	141.57	-24.1	-36.69	4.72	-2.48
Common Equity, 2 Yr. CAGR %	20.89	15.17	12.98	1.16	-0.89
Cash From Operations, 2 Yr. CAGR %	45.43	17.14	-7.42	-11.4	-5.36
Capital Expenditures, 2 Yr. CAGR %	42.64	20.68	5.61	11.58	-8.57
Levered Free Cash Flow, 2 Yr. CAGR %	33.14	10.61	1.48	-1.35	-2.71
Unlevered Free Cash Flow, 2 Yr. CAGR %	33.48	9.86	1.78	-0.84	-2.75
Dividend Per Share, 2 Yr. CAGR %	11.14	17.85	11.8	3.92	10.41
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	19.99	20.67	2.35	-1.26	-2.67
Gross Profit, 3 Yr. CAGR %	23.85	23.81	2.7	-2.48	-3.49
EBITDA, 3 Yr. CAGR %	34.29	34.86	4.62	-6.37	-6.95
EBITA, 3 Yr. CAGR %	37.42	37.82	4.9	-7.13	-7.76
EBIT, 3 Yr. CAGR %	38.27	38.63	3.77	-10.05	-10.81
Earnings From Cont. Operations, 3 Yr. CAGR %	38.17	43.65	5	-10.55	-17.14
Net Income, 3 Yr. CAGR %	34.38	33.82	9.32	-15.37	-20.56
Normalized Net Income, 3 Yr. CAGR %	38.92	37.3	5.36	-10.06	-11.49
Diluted EPS Before Extra, 3 Yr. CAGR %	35.83	43.63	4.97	-10.08	-15.94
Accounts Receivable, 3 Yr. CAGR %	14.17	15.29	-1.1	-9.08	-2.17
Inventory, 3 Yr. CAGR %	19.26	24.08	4.21	-5.57	-3.44
Net Property, Plant and Equip., 3 Yr. CAGR %	29.02	17.37	10.06	7.93	13.67
Total Assets, 3 Yr. CAGR %	20.26	10.76	3.52	-2.31	-0.35
Tangible Book Value, 3 Yr. CAGR %	68.21	45.32	-24	-24.5	-0.97
Common Equity, 3 Yr. CAGR %	14.09	19.08	13.59	5.74	2.76
Cash From Operations, 3 Yr. CAGR %	27.61	29.18	4.89	-7.16	-9.02
Capital Expenditures, 3 Yr. CAGR %	30.37	21.9	20.47	3.93	1.12
Levered Free Cash Flow, 3 Yr. CAGR %	26.84	21.83	2.08	-0.32	-1.77
Unlevered Free Cash Flow, 3 Yr. CAGR %	26.65	21.9	2.05	-0.11	-1.46
Dividend Per Share, 3 Yr. CAGR %	9.49	13.72	13.4	8.74	8.58
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	11.77	15.19	6.98	5.92	1.97
Gross Profit, 5 Yr. CAGR %	14.04	17.19	8.25	7.35	2.21
EBITDA, 5 Yr. CAGR %	20.72	24.13	12.08	10.92	3.5
EBITA, 5 Yr. CAGR %	22.5	26.3	13.14	11.68	3.51
EBIT, 5 Yr. CAGR %	22.98	27.42	11.73	9.45	2.24
Earnings From Cont. Operations, 5 Yr. CAGR %	24.13	27.11	11.9	9.9	-0.25
Net Income, 5 Yr. CAGR %	20.3	23.67	12.44	5.33	-0.18
Normalized Net Income, 5 Yr. CAGR %	23.91	28.25	12.75	8.56	2.19
Diluted EPS Before Extra, 5 Yr. CAGR %	22.51	25.7	10.75	10.16	0.59
Accounts Receivable, 5 Yr. CAGR %	7.77	7.3	5.02	1.59	-0.98
Inventory, 5 Yr. CAGR %	10.11	11.06	9.72	7.43	1.66
Net Property, Plant and Equip., 5 Yr. CAGR %	15.46	15.09	20.03	14.65	9.92
Total Assets, 5 Yr. CAGR %	12.93	12.58	12.05	4.55	1.85
Tangible Book Value, 5 Yr. CAGR %	11.85	2.18	13.79	20.22	-16.03
Common Equity, 5 Yr. CAGR %	12.74	12.93	13.65	11.56	7.56
Cash From Operations, 5 Yr. CAGR %	18.87	19.62	12.24	11.1	0.66
Capital Expenditures, 5 Yr. CAGR %	17.02	15.08	18.82	16.96	7.88
Levered Free Cash Flow, 5 Yr. CAGR %	15.48	22.65	12.6	8.62	-0.07
Unlevered Free Cash Flow, 5 Yr. CAGR %	15.12	22.18	12.7	8.94	-0.1
Dividend Per Share, 5 Yr. CAGR %	8.06	12.3	10.41	9.69	12.2